Incyte (INCY) Tops Q3 EPS by 67c; raises guidance
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $126.75 -0.98%
EPS Growth %: -225.2%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q3 EPS of $2.26, $0.67 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.25 billion.
GUIDANCE:
Incyte raises FY2025 net product revenue of $4.23-4.32 billion.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
